4AB•XETRA (Frankfurt)•Healthcare•Germany•$319.46B

Stocks Similar to 4AB

Top 20 stocks similar to AbbVie Inc based on sector, industry, market cap, and valuation multiples. Same-industry peers (Drug Manufacturers - General) are ranked first.

Company	Industry	Market Cap	P/E	Yield	Change	Compare
AbbVie Inc ABBV • United States	Drug Manufacturers - General	$367.80B	87.7	3.13%	+0.21%	vs
CHUGAI PHARMACEUTICAL CO.,LTD. 4519 • Japan	Drug Manufacturers - General	$87.52B	—	—	+2.16%	vs
AstraZeneca PLC AZN • United States	Drug Manufacturers - General	$316.30B	31.1	1.56%	+0.38%	vs
Novartis AG NOVN • Switzerland	Drug Manufacturers - General	$296.92B	21.5	3.82%	-2.87%	vs
AstraZeneca PLC ZEG • Germany	Drug Manufacturers - General	$308.99B	29.0	2.00%	+0.00%	vs
RO Roche Holding AG ROP • Switzerland	Drug Manufacturers - General	$319.37B	19.6	3.11%	+1.39%	vs
Roche Holding AG ROG • Switzerland	Drug Manufacturers - General	$327.71B	20.1	3.06%	-6.01%	vs
AstraZeneca PLC AZNCF • United States	Drug Manufacturers - General	$290.60B	31.1	1.70%	+2.63%	vs
Roche Holding AG RO • Switzerland	Drug Manufacturers - General	$329.84B	20.2	2.98%	+0.97%	vs
Novartis AG ADR NVS • United States	Drug Manufacturers - General	$297.35B	21.5	3.08%	-1.35%	vs
Novartis AG NVSEF • United States	Drug Manufacturers - General	$298.59B	21.9	2.98%	-3.50%	vs
Roche Holding AG Participation RHHVF • United States	Drug Manufacturers - General	$322.60B	19.8	2.57%	+0.99%	vs
Roche Holding AG RHHBF • United States	Drug Manufacturers - General	$333.09B	20.7	2.38%	-0.62%	vs
MR Merck & Company Inc MRK • Austria	Drug Manufacturers - General	$302.62B	16.6	3.10%	-4.52%	vs
AstraZeneca PLC AZN • Sweden	Drug Manufacturers - General	$316.82B	30.4	0.17%	-1.58%	vs
Merck & Company Inc MRK • United States	Drug Manufacturers - General	$300.20B	16.7	2.64%	-1.94%	vs
AM Amgen Inc. AMG • Germany	Drug Manufacturers - General	$190.85B	24.8	3.23%	-0.05%	vs
Roche Holding AG ROGN • Mexico	Drug Manufacturers - General	$360.03B	20.7	0.13%	+0.00%	vs
AM Amgen Inc AMGN • United States	Drug Manufacturers - General	$189.22B	24.7	2.68%	+1.22%	vs
Gilead Sciences Inc GIS • Germany	Drug Manufacturers - General	$171.20B	20.3	2.68%	-2.31%	vs

How we rank similar stocks

Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.

View all Healthcare stocks →